Expired activity
Please go to the PowerPak
homepage and select a course.
Interprofessional Team Management of Multidrug-Resistant Gram-Negative Bacterial Infections
Provided by American Academy of CME, Inc.
This educational activity is supported by an educational grant from Merck.
Release date
January 30, 2019
Expiration date
January 30, 2020
Estimated time to complete activity
1.75 hours
Activity Description
The number of formally ID-trained pharmacist are limited across the country. This means that there is a growing role for general pharmacists to collaborate with physicians to optimally manage patients' antibiotics in their hospital or unit as well as fulfill necessary drug expert roles in antibiotic stewardship programs. In order to effectively work together, pharmacists and physicians need education regarding the current state of drug-resistant infections and current/emerging antibiotic therapies. Pharmacists in particular need to understand the nuances of new antibiotics for treatment of MDR GNB and their role on the hospital formulary. Along with enhanced knowledge of this complex area of infectious diseases management, the ability of members of the care team to effectively communicate their knowledge and educate other team members will be fostered and fulfilled.
Faculty Educators
Navaneeth Narayanan, PharmD, MPH, BCPS
Clinical Assistant Professor
Department of Pharmacy Practice
Rutgers University, Ernest Mario School of Pharmacy
Adjunct Assistant Professor
Division of Infectious Diseases, Department of Medicine
Rutgers Robert Wood Johnson Medical School
Infectious Diseases Clinical Pharmacist
Pharmacist Director, Antimicrobial Stewardship
Robert Wood Johnson University Hospital, New Brunswick
RWJBarnabas Health
Julia Cornett, MD
Assistant Professor
Division of Infectious Diseases, Department of Medicine
Rutgers Robert Wood Johnson Medical School
Target Audience
This activity has been designed to meet the educational needs of pharmacists and physicians who may be involved in the management of multidrug-resistant gram-negative bacterial infections. Other healthcare professionals may also participate.
Learning Objectives
- Describe the epidemiology and mechanisms of drug-resistance among Gram-negative bacterial (GNB) infections
- Analyze the pharmacology and antibacterial activity of current and emerging antibiotic therapies for multidrug-resistant (MDR) GNB infections included ESBL-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae, and multidrug-resistant Pseudomonas aeruginosa.
- Explain the evidence and utility of new antibiotic therapies for MDR GNB infections
- Evaluate the role of the pharmacist and infectious disease physician in managing antibiotic therapies for MDR GNB infections and their role as antibiotic stewardship program members
Accreditation and Credit Designation
American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacists
This activity provides 1.75 contact hours (0.175 CEUs) of continuing education credit. ACPE Universal Activity Number (UAN): JA4008191-0000-19-001-H01-P; Application
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are able to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Disclosures are as follows:
Faculty Educators
Navaneeth Narayanan, PharmD, BCPS
No relevant financial relationships with commercial interests.
Julia Cornett, MD
Grant/Research Support: Gilead Sciences - Principal Investigator (funds are directly sent to Rutgers-RWJMS)
Planning Committee
John JD Juchniewicz, MCIS, CHCP, Wendy Gloffke, PhD and Paul J. Miniter, MS
No relevant financial relationships with any commercial interests.
External Reviewer
Michelle L. Kohute, PharmD, BCCCP
No relevant financial relationships with commercial interests.
This activity will not review off-label or investigational information.
Disclaimer
The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
Method of Participation
There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CPE/CME credit for your participation, please complete the post-test (achieving a passing grade of 70% or greater), and program evaluation. Your certificate can be printed immediately. For pharmacists, a statement of credit will be issued through CPE Monitor in 6-8 weeks. Only learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.
Hardware/Software Requirements
Please ensure the computer you plan to use meets the following minimum requirements:
- Operating System: Windows 98 or higher & Macintosh 2.2 or higher
- Internet Browser (Mac &/ Windows): Internet Explorer 6.0 or higher, Google Chrome, Safari 5.0.6 or higher, Firefox 3.0.3 or higher & Opera 5 or higher
- Broadband Internet connection: Cable, High-speed DSL & any other medium that is internet accessible
- Monitor Screen Resolution: 320 x 480 or higher
- Media Viewing Requirements: Adobe Reader, Microsoft Powerpoint, Flash Player & HTML5
Privacy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm
Contact
For any questions, please contact: CEServices@academycme.org
Copyright
© 2019. This CPE/CME-certified activity is held as copyrighted © by American Academy of CME, Inc. Through this notice, the Academy grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
